11 Best Stocks Under 3 Dollars to Buy For November 2022

For investors willing to stray from the beaten path, the universe of cheap stocks contains a multitude of intriguing bargains. Penny stocks are one of the most volatile asset classes.

Not even a few hundred dollars is sufficient capital for many people to invest in the stock market, despite their desire to do so. However, this is not an issue in the world of penny stocks, as it is sometimes possible to purchase shares at low prices.

The Pros and Cons of Investing in Stocks Less Than $3

The pros of investing in penny stocks include the following:

(1) Minimal Investment Required: Due to the low cost of penny stocks, even those on a tight budget can easily begin trading.

(2) Large Share Volumes: An investor with $300 to buy may only be able to purchase one or two shares of a larger company, whereas he or she could purchase hundreds or thousands of shares of penny stocks.

(3) Climbing The Investment Ladder: Even the largest and most lucrative businesses must begin somewhere. You could make a wise long-term investment in the company’s future growth by purchasing shares of penny stocks.

The cons of buying penny stocks include the following:

  • The purchase of penny stocks is not for the faint of heart or for investors who prefer to buy and hold. Due to the diminutive size of the market for penny stocks, relatively low trading volumes can spark sharp increases and decreases in stock prices, thereby increasing their volatility.
  • Vulnerable to Scams: Investors pay less attention to penny stocks, making it more difficult to find legitimate information and more likely for fraudulent schemes to emerge.

There is a “get rich quick” scheme with an artificially inflated stock price caused by fraudulent trading activity for every story of successful investment in penny stocks.

How to Locate The Best Stocks Under $3 to Buy Now

In the following seconds, we will discuss the most important considerations when looking for the best stocks under $3 for your portfolio.

Financial Results

Financial statements are essential for identifying the best stocks under $3 because they reveal a great deal about a company’s overall health, including operating expenses, revenue, debt, and profitability.

Not to mention the organization’s ability to meet its short- and long-term financial obligations.

The SEC requires quarterly reports from publicly traded corporations. Each report will include details on plans and forecasts, operating expenses, cash flows, and recent profits.

Below are some things you may wish to consider:

What was the previous quarter’s performance for the company?

How does this quarter’s performance compare to the previous quarter?

Have quarterly revenue increases or decreases occurred?

The days preceding and following the release of an earnings report are crucial for monitoring a company’s stock price. The price of a company’s stock can increase or decrease dramatically depending on whether or not it meets its earnings projections.

Price to Earnings Ratio

The price-to-earnings ratio, or P/E, can be used to determine whether stocks under $3 are undervalued or overvalued.

In brief, the P/E ratio indicates how much the market is willing to pay for a company based on its past or projected profits.

Comparing a company’s price-to-earnings ratio to that of other companies in the same industry can also help determine whether it is fairly valued.

A high P/E ratio may indicate that a stock is overvalued due to its high price relative to its earnings. On the other hand, an increase in the P/E ratio of a company may also indicate that its financial fundamentals have improved, thereby justifying the higher value.

A low P/E ratio may indicate that a company is currently inexpensive, and this can also indicate that the stock is performing exceptionally well relative to its historical patterns. Numerous investors use the P/E ratio to compare a stock to the market as a whole.

Passive Income

Passive income is not a deal-breaker when searching for the best stocks under $3, but if you’re interested in it, keep an eye out for dividends.

For example, Lloyds TSB is the best dividend stock for less than $3. At the time of writing, the financial institution’s dividend yield is 4.6%.


Small-cap stocks are typically more volatile than large-cap stocks. Nevertheless, as we’ve discussed, some penny stocks also fall into this category.

Determine your risk tolerance prior to identifying the best stocks under $3 for you.

Are you aiming for above-average returns?

If so, you could be categorized as a high-risk investor.

Alternatively, are you interested in long-term stability and willing to accept a lower rate of return?

Consequently, you are likely a low-risk investor.

The majority of investors are middle-of-the-road. Therefore, diversity is essential. You should also consider learning how to conduct technical analysis. Some investors use standard deviation to gauge the market’s volatility.

In other words, if share prices are experiencing sharp swings in either direction, the standard deviation is likely to be high, indicating a more volatile and risky stock.

11 Best Stocks Under 3 Dollars to Invest in

CohBar (CWBR)

CohBar is a company attempting to gain a deeper understanding of the mitochondrial genome in order to develop therapeutic peptides. Its business is based on the premise that these peptides have been conserved by evolutionary biology because they regulate essential biological functions. The company identifies these peptides and then creates potential therapeutic analogs.

As with the majority of penny stocks, the bullish case for CohBar is not unquestionable. The company recently announced positive findings from its Phase 1a/1b study of a treatment for nonalcoholic steatohepatitis. In addition, Cantor Fitzgerald has recently initiated coverage and published a research report on the company. This is a positive indicator, and three firms now cover CWBR stock.

CohBar shares, like all penny stocks on the list, have a strong upside. It is currently trading at 35 cents, but the three firms that cover it believe it could be worth an average of $3.83. Therefore, 2022 could be an excellent year to own CWBR stock.

InPlay Oil (IPOOF)

If you missed the boat on purchasing crude oil-based investments this year, you could strike gold with InPlay Oil (OTCMKTS: IPOOF). According to their official website, InPlay is growth-focused light oil development and production firm headquartered in Calgary, Alberta.

In addition, the company asserts that it is “focused on large oil in place pools with low recovery factors, low declines, and long life reserves, specifically targeting the Cardium Formation in Alberta. InPlay’s solid financial position enables it to withstand commodity price volatility and expand its inventory of horizontal drilling locations.”

The fundamental narrative is interesting from the perspective of the best penny stocks under $3. Russia’s invasion of Ukraine completely shattered the modern global order, and the pursuit of energy independence has reached a fever pitch today. Therefore, it would not surprise me if IPOOF stock attracted speculative interest.

ObsEva (OBSV)

ObsEva produces therapeutics for the reproductive health of women. In 2022, I believe there are two primary reasons to consider purchasing OBSV stock.

Let’s begin by examining the fundamental business. Unlike other biotechs and penny stocks, it is not a particularly risky investment. The most recent earnings report indicates that the company is in a strong position.

ObsEva reported a net profit of $800,000 for the quarter ending September 30. This was a significant improvement from the previous year’s $24.4 million loss.

The company’s cash position has significantly improved since the beginning of 2021. ObsEva reported a cash position of $62.9 million on September 30, up from $31.2 million at the end of 2020.

In addition to these fundamental factors, ObsEva has recently been added to the Nasdaq Biotechnology Index, which is a further positive development.


Lloyds is a UK-based financial institution. The organization provides a variety of services, including insurance, mortgages, vehicle financing, credit cards, loans, and savings accounts. Lloyds owns a number of other businesses, including Scottish Widows, Halifax, the Bank of Scotland, and a few insurance firms.

With an asset base of about £885 billion (almost $1.1 trillion), Lloyds is about as plain as banks. Lloyds’s core deposit brand stands out as particularly appealing. Group is the UK market leader in deposits despite competing in a very competitive industry.

In addition, nearly two-thirds of the £450 billion (approximately $585 billion) in loans to customers are retail mortgages. This company is listed on the LSE, but its shares are also available on the NASDAQ. In May 2002, Lloyds’ NASDAQ-listed stock surpassed $47, its all-time high. Before falling again, the stock market did not approach that level for five more years.

Vista Gold (VGZ)

Vista Gold is the only non-biotechnology or medicine company on this list, and it is, as expected, a gold mining company. The basic premise for investing in VGZ stock is that if a few obstacles are overcome, the stock’s target price of $2.36 could be reached.

The definitive feasibility study for the development of the company’s Mt. Todd property is one of the most significant obstacles. This is anticipated to be completed by the start of 2022. It is one of several obstacles the company must overcome in order to develop its gold-producing assets and complete construction planning.

A step-by-step listing of these obstacles can be found on page 4 of the company’s most recent investor presentation. Again, if the company checks all of these boxes, it will be able to reach the target price in 2022. The fact that all three analysts who cover VGZ rate it as a buy are encouraging.

Ambev SA (ticker: ABEV)

Ambev is the operating division of global beer giant Anheuser-Busch InBev SA in Latin America (BUD). Ambev sells Anheuser-Busch Inbev beers primarily in Brazil, Argentina, and other countries in South America. Numerous investors have a negative opinion of the parent company as a result of its high debt load and slow growth. However, Ambev doesn’t have those same problems. In the first place, craft beer has not had nearly the same impact on market share in Latin America as it has in economies with greater wealth. In addition, Ambev maintains a solid balance sheet with minimal long-term liabilities, providing it with significantly greater financial flexibility than its corporate parent. Ambev shares trade for less than 20 times expected future earnings. In addition, the upcoming World Cup should serve as a catalyst for bar and restaurant spending patterns in South American nations to return to pre-pandemic levels. On September 6, Ambev shares closed at $2.93.

Exela Technologies Inc. (NASDAQ: XELA) 

With gains of over 1.7% during today’s trading, Exela Technologies is another penny stock that investors should monitor. At less than $0.50 per share, Exela has continued to make significant industry advances. Prior to discussing why Exela is relocating, it is important to understand what the company does. Exela is a business process automation, or BPA, firm.

It provides a variety of these solutions to more than 4,000 customers across the globe. The company’s most recent announcement was made on April 28. It announced on February 28 that it had signed a multi-year licensing agreement with Finanz Informatik. This is an IT service provider for Savings Banks Finance Group, which manages assets worth more than $3.5 trillion.

ECA Marcellus Trust (ECTM)

ECA Marcellus Trust (OTCMKTS: ECTM) may be of interest if you are looking to increase your exposure to the hydrocarbon industry. ECA is a special-purpose financing vehicle structured as a royalty income trust that allows its investors to share in the income generated from natural gas deposits.

Massive performance is the defining characteristic that sets ECA Marcellus apart from the competition from the outset. As of July 1st, ECTM is up a staggering 169% year-to-date. Nevertheless, with the above-mentioned fundamentals, ECTM could rise further. In any case, the U.S.-led sanctions against Russia have effectively halted a substantial portion of global energy production.

In addition to ECTM’s inherent volatility, investors should recognize a significant deterrent. Royalty income trusts have a very complicated and time-consuming tax filing process. ECTM could be intriguing if you desire substantial upside potential from the best penny stocks.

Bionano Genomics

Bionano Genomics specializes in optical genome mapping technology used in medical research. The company provides a platform for analyzing the structural variations of large DNA segments and other biomolecules.

The company’s products consist of nanochannel chips, automated imaging devices, application-specific reagents, and integrated primary and secondary software. Bionano Genomics’ Saphyr genome-mapping equipment has numerous clinical and academic applications, ranging from the detection of genetic abnormalities and cancer research to crop engineering.

Any clinic or laboratory with Saphyr will need to buy microfluidic sample chips and preparation kits frequently. Additionally, more frequent use of the device will necessitate additional purchases. Consequently, Bionano Genomics is well on its way to establishing its own ecosystem.

Biolase (BIOL)

Biolase sells dental laser systems that enable minimally invasive dental procedures. Despite the fact that the company has sold over 41,200 laser dental systems to date, it is evidently risky.

The share price of Biolase has remained below $1 for the majority of this year. And on November 23, the company was granted a 180-day extension to regain compliance with the Nasdaq minimum stock price requirement of $1.

Nonetheless, there are numerous advantages to consider. Biolase’s target price of $2.31 implies enormous potential gains, given the stock’s current price of $0.40 per share. These gains are likely the result of the company’s ongoing capacity to enhance its operations.

On the one hand, Biolase’s third-quarter revenue increased by 46% to $9.5 million. Additionally, 78% of laser sales in the United States came from new customers, indicating a company with highly marketable products. Overall, laser system sales increased by 64%. However, third-quarter net losses of $10.88 million were roughly the same as a year ago. In conclusion, there is a risk.

However, Biolase maintains a solid cash position, and if sales continue to rise in 2022, the stock price should rise.

Mizuho Financial Group Inc. (MFG)

Mizuho is among Japan’s three largest banking franchises. Theoretically, holding a substantial market share in one of the world’s richest and most technologically advanced economies should be an enviable position. Since the early 1990s, Japan has experienced numerous recessions and deflationary stagnation.

For many years, Japan’s central bank has kept interest rates at or near zero, leaving banks with meager profit margins. All of this may soon change, however. The rise in global inflation may finally force Japan to adopt higher interest rates, which would be a positive development for Mizuho. The decline in the value of the Japanese yen increases the desirability of stocks for American investors. In addition, Mizuho is trading at just seven times forward earnings and offers a dividend yield of 5.8%. On September 6, shares closed at $2.26 per share.

Final Thoughts

Under $3 stocks range from small start-ups with the potential to become wealthy to schemes designed to steal people’s retirement savings. This article has discussed some penny stocks with tremendous growth potential, but it is ultimately your decision where to invest.

Leave a Comment